Refine
Year of publication
Document Type
- Article (221)
- Preprint (116)
- Part of Periodical (5)
- Doctoral Thesis (4)
- Part of a Book (1)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (349)
Is part of the Bibliography
- no (349)
Keywords
- BESIII (15)
- taxonomy (13)
- Branching fraction (9)
- e +-e − Experiments (9)
- Fulgoroidea (6)
- Hadronic decays (5)
- Oriental region (5)
- Particle and Resonance Production (5)
- Quarkonium (5)
- Branching fractions (4)
Institute
- Physik (240)
- Frankfurt Institute for Advanced Studies (FIAS) (37)
- Medizin (25)
- Biowissenschaften (8)
- Biochemie und Chemie (4)
- Informatik (2)
- Institut für Ökologie, Evolution und Diversität (2)
- Kulturwissenschaften (2)
- Pharmazie (2)
- Psychologie (2)
In the mouse, most mature olfactory sensory neurons (OSNs) express one allele of one gene from the repertoire of ~1100 odorant receptor (OR) genes, which encode G-protein coupled receptors (GPCRs). Axons of OSNs that express a given OR coalesce into homogeneous glomeruli, which reside at conserved positions in the olfactory bulb. ORs are intimately involved in ensuring the expression of one OR per OSN and the coalescence of OSN axons into glomeruli. But the mechanisms whereby ORs accomplish these diverse functions remain poorly understood. An experimental approach that has been informative is to substitute an OR genetically with another GPCR that is normally not expressed in OSNs, in order to determine in which aspects this GPCR can serve as surrogate OR in mouse OSNs. Thus far only the β2-adrenergic receptor (β2AR, Ardb2) has been shown to be able to serve as surrogate OR in OSNs; the β2AR could substitute for the M71 OR in all aspects examined. Can other non-olfactory GPCRs function equally well as surrogate ORs in OSNs? Here, we have generated and characterized two novel gene-targeted mouse strains in which the mouse melanocortin 4 receptor (Mc4r) or the mouse dopamine receptor D1 (Drd1a) is coexpressed with tauGFP in OSNs that express the OR locus M71. These alleles and strains are abbreviated as Mc4r→M71-GFP and Drd1a→M71-GFP. We detected strong Mc4r or Drd1a immunoreactivity in axons and dendritic knobs and cilia of OSNs that express Mc4r or Drd1a from the M71 locus. These OSNs responded physiologically to cognate agonists for Mc4r (Ro27-3225) or Drd1a (SKF81297), and not to the M71 ligand acetophenone. Axons of OSNs expressing Mc4r→M71-GFP coalesced into glomeruli. Axons of OSNs expressing Drd1a→M71-GFP converged onto restricted areas of the olfactory bulb but did not coalesce into glomeruli. Thus, OR functions in OSNs can be substituted by Mc4r or Drd1a, but not as well as by β2AR. We attribute the weak performance of Drd1a as surrogate OR to poor OSN maturation.
The current knowledge of the scorpionfly genus Dicerapanorpa Zhong & Hua, 2013 is taxonomically reviewed. Two new species of Dicerapanorpa are described and illustrated, increasing the species number of this genus to 20. Dicerapanorpa bifurcata sp. nov. from the Minshan Mountains, Sichuan Province, is characterized by the absence of the paramere basal branch and the elongated mesal branch in males, and the medigynium having a short basal stalk in females. Dicerapanorpa zhengkuni sp. nov. from the Wuling and Miaoling Mountains, Guizhou Province, is distinguishable by the greatly elongated hypovalves, the very short basal branch of the paramere, and the dorsomedially curved lateral branch in males, and the rounded main plate of the medigynium in females. An updated key to species of Dicerapanorpa is presented.
Die Analyse früher Entwicklungsstadien von Säugetierembryonen und daraus gewonnener Stammzelllinien kann entscheidende Erkenntnisse im Bereich der Reproduktionsbiologie und der regenerativen Medizin hervorbringen. Dabei spielt die Maus, als geeignetes Modellsystem für die Übertragbarkeit auf den Menschen eine wichtige Rolle, in erster Linie weil die Blastozysten der Maus verglichen mit menschliche Blastozysten eine morphologische Ähnlichkeit aufweisen. Humane embryonale Stammzelllinien haben großes Potential für die Anwendung in der regenerativen Medizin und vergleichend dazu wurde Gen-Targeting in embryonalen Stammzellen verwendet, um tausende neuer Mausstämme zu generieren. Die Gewinnung embryonaler Stammzellen erfolgt im Blastozystenstadium, diese können dann nach Injektion in eine andere Blastozyste zur Entwicklung aller Gewebearten, einschließlich der Keimbahngewebe, beitragen (Martin, 1981; Evans and Kaufman 1981).
Ursache einer Fehlgeburt können vor allem Defekte in der Entwicklung des Trophoblasten und des primitive Entoderms (PrE) sein, dabei sind ca. 5 % der Paare betroffen die versuchen ein Kind zu bekommen (Stephenson and Kutteh, 2007). Eine Untersuchung dieser Zelllinien im Mausmodell könnte weitere Erkenntnisse für die Gründe einer Fehlentwicklung liefern. Trophoblasten Stammzelllinien können aus den Blastozysten der Maus und dem extraembryonalen Ektoderm von bereits implantieren Embryonen gewonnen werden (Tanaka et al., 1998). Diese Zelllinien geben Aufschluss über die Entwicklung des Trophoblasten, fördern die Entwicklung der Plazenta und sind gleichzeitig ein gutes Modellsystem um die Implantation des Embryos im Uterus näher zu untersuchen. Zellen des primitive Entoderms (PrE) beeinflussen das im Dottersack vorhandene extraembryonale Entoderm, welches dort als “frühe Plazenta” fungiert und für die Versorgung des Embryos mit Nährstoffen zuständig ist (Cross et al., 1994). Des Weiteren besitzt das Entoderm einen induktiven Einfluss auf die Bildung von anterioren Strukturen und die Bildung von Endothelzellen sowie Blutinseln (Byrd et al., 2002).
Extraembryonale Endodermstammzellen (XEN Zellen) können aus Blastozysten gewonnen und in embryonale Stammzellen (ES-Zellen) umgewandelt werden (Fujikura et al., 2002; Kunath et al., 2005). Es war jedoch nicht bekannt, ob XEN-Zellen auch aus Postimplantations-Embryonen gewonnen werden können. XEN-Zellen tragen in vivo zur Entwicklung des Darmendoderms bei (Kwon et al., 2008; Viotti et al., 2014) und könnten als alternative, selbsterneuernde Quelle für extraembryonale Endoderm-abgeleitete Zellen dienen, die zur Herstellung von Geweben für die regenerative Medizin verwendet werden könnten (Niakan et al., 2013).
In der Embryogenese der Maus zeigt sich an Tag E3.0 eine kompakte Morula die sich allmählich in das Trophektoderm (TE) differenziert, welches wiederum den Embryonalknoten (“innere Zellmasse”) umschließt (Johnson and Ziomek, 1981). Ein wichtiger Schritt im Rahmen der Entwicklung findet an Tag E3.5 statt, in diesem Zeitraum gehen aus dem Embryonalknoten der pluripotente Epiblast und das primitive Entoderm hervor. Im späten Blastozystenstadium an Tag E4.5 liegt das PrE als Zellschicht entlang der Oberfläche der Blastocoel-Höhle. Aus dem Epiblast entwickeln sich im weiteren Verlauf der Embryo, das Amnion und das extraembryonale Mesoderm des Dottersacks. Die Zellen des Trophektoderm führen zur Entwicklung der Plazenta. Das PrE differenziert sich im Zuge der Weiterentwicklung in das viszerale Entoderm (VE) und das parietale Entoderm (PE) des Dottersacks (Chazaud et al., 2006; Gardner and Rossant, 1979; Plusa et al., 2008). VE umgibt den Epiblast und extraembryonisches Ektoderm (ExE). PE-Zellen wandern entlang der inneren Oberfläche von TE und sezernieren zusammen mit Trophoblasten-Riesenzellen Basalmembranproteine, um die Reichert-Membran zu bilden (Hogan et al., 1980). Die Reichert-Membran besteht aus Basalmembranproteinen, einschließlich Kollagenen und Lamininen, die zwischen den parietalen Endoderm- und Trophoblastzellen liegen. Diese Membran wirkt als ein Filter, der dem Embryo den Zugang zu Nährstoffen ermöglicht, während er eine Barriere zu den Zellen der Mutter bildet (Gardner, 1983).
...
A wealth of data has elucidated the mechanisms by which sensory inputs are encoded in the neocortex, but how these processes are regulated by the behavioral relevance of sensory information is less understood. Here, we focus on neocortical layer 1 (L1), a key location for processing of such top-down information. Using Neuron-Derived Neurotrophic Factor (NDNF) as a selective marker of L1 interneurons (INs) and in vivo 2-photon calcium imaging, electrophysiology, viral tracing, optogenetics, and associative memory, we find that L1 NDNF-INs mediate a prolonged form of inhibition in distal pyramidal neuron dendrites that correlates with the strength of the memory trace. Conversely, inhibition from Martinotti cells remains unchanged after conditioning but in turn tightly controls sensory responses in NDNF-INs. These results define a genetically addressable form of dendritic inhibition that is highly experience dependent and indicate that in addition to disinhibition, salient stimuli are encoded at elevated levels of distal dendritic inhibition.
Extraembryonic endoderm stem (XEN) cell lines can be derived and maintained in vitro and reflect the primitive endoderm lineage. Platelet-derived growth factor receptor alpha (PDGFRA) is thought to be essential for the derivation and maintenance of mouse XEN cell lines. Here, we have re-evaluated this requirement for PDGFRA. We derived multiple PDGFRA-deficient XEN cell lines from postimplantation and preimplantation embryos of a PDGFRA-GFP knockout strain. We also converted PDGFRA-deficient embryonic stem cell lines into XEN cell lines chemically by transient culturing with retinoic acid and Activin A. We confirmed the XEN profile of our 12 PDGFRA-deficient cell lines by immunofluorescence with various markers, by NanoString gene expression analyses, and by their contribution to the extraembryonic endoderm of chimeric embryos produced by injecting these cells into blastocysts. Thus, PDGFRA is not essential for the derivation and maintenance of XEN cell lines.
Transcatheter left atrial appendage occlusion (LAAO) is non-inferior to vitamin K antagonists (VKAs) in preventing thromboembolic events in atrial fibrillation (AF). Non-vitamin K antagonists (NOACs) have an improved safety profile over VKAs; however, evidence regarding their effect on cardiovascular and neurological outcomes relative to LAAO is limited. Up-to-date randomized trials or propensity-score-matched data comparing LAAO vs. NOACs in high-risk patients with AF were pooled in our study. A total of 2849 AF patients (LAAO: 1368, NOACs: 1481, mean age: 75 ± 7.5 yrs, 63.5% male) were enrolled. The mean CHA2DS2-VASc score was 4.3 ± 1.7, and the mean HAS-BLED score was 3.4 ± 1.2. The baseline characteristics were comparable between the two groups. In the LAAO group, the success rate of device implantation was 98.8%. During a mean follow-up of 2 years, as compared with NOACs, LAAO was associated with a significant reduction of ISTH major bleeding (p = 0.0002). There were no significant differences in terms of ischemic stroke (p = 0.61), ischemic stroke/thromboembolism (p = 0.63), ISTH major and clinically relevant minor bleeding (p = 0.73), cardiovascular death (p = 0.63), and all-cause mortality (p = 0.71). There was a trend toward reduction of combined major cardiovascular and neurological endpoints in the LAAO group (OR: 0.84, 95% CI: 0.64–1.11, p = 0.12). In conclusion, for high-risk AF patients, LAAO is associated with a significant reduction of ISTH major bleeding without increased ischemic events, as compared to “contemporary NOACs”. The present data show the superior role of LAAO over NOACs among high-risk AF patients in terms of reduction of major bleeding; however, more randomized controlled trials are warranted.
Background: Macrophage Migration Inhibitory Factor (MIF) is highly elevated after cardiac surgery and impacts the postoperative inflammation. The aim of this study was to analyze whether the polymorphisms CATT5–7 (rs5844572/rs3063368,“-794”) and G>C single-nucleotide polymorphism (rs755622,-173) in the MIF gene promoter are related to postoperative outcome. Methods: In 1116 patients undergoing cardiac surgery, the MIF gene polymorphisms were analyzed and serum MIF was measured by ELISA in 100 patients. Results: Patients with at least one extended repeat allele (CATT7) had a significantly higher risk of acute kidney injury (AKI) compared to others (23% vs. 13%; OR 2.01 (1.40–2.88), p = 0.0001). Carriers of CATT7 were also at higher risk of death (1.8% vs. 0.4%; OR 5.12 (0.99–33.14), p = 0.026). The GC genotype was associated with AKI (20% vs. GG/CC:13%, OR 1.71 (1.20–2.43), p = 0.003). Multivariate analyses identified CATT7 predictive for AKI (OR 2.13 (1.46–3.09), p < 0.001) and death (OR 5.58 (1.29–24.04), p = 0.021). CATT7 was associated with higher serum MIF before surgery (79.2 vs. 50.4 ng/mL, p = 0.008). Conclusion: The CATT7 allele associates with a higher risk of AKI and death after cardiac surgery, which might be related to chronically elevated serum MIF. Polymorphisms in the MIF gene may constitute a predisposition for postoperative complications and the assessment may improve risk stratification and therapeutic guidance.
Variants resistant to compounds specifically targeting HCV are observed in clinical trials. A multi-variant viral dynamic model was developed to quantify the evolution and in vivo fitness of variants in subjects dosed with monotherapy of an HCV protease inhibitor, telaprevir. Variant fitness was estimated using a model in which variants were selected by competition for shared limited replication space. Fitness was represented in the absence of telaprevir by different variant production rate constants and in the presence of telaprevir by additional antiviral blockage by telaprevir. Model parameters, including rate constants for viral production, clearance, and effective telaprevir concentration, were estimated from 1) plasma HCV RNA levels of subjects before, during, and after dosing, 2) post-dosing prevalence of plasma variants from subjects, and 3) sensitivity of variants to telaprevir in the HCV replicon. The model provided a good fit to plasma HCV RNA levels observed both during and after telaprevir dosing, as well as to variant prevalence observed after telaprevir dosing. After an initial sharp decline in HCV RNA levels during dosing with telaprevir, HCV RNA levels increased in some subjects. The model predicted this increase to be caused by pre-existing variants with sufficient fitness to expand once available replication space increased due to rapid clearance of wild-type (WT) virus. The average replicative fitness estimates in the absence of telaprevir ranged from 1% to 68% of WT fitness. Compared to the relative fitness method, the in vivo estimates from the viral dynamic model corresponded more closely to in vitro replicon data, as well as to qualitative behaviors observed in both on-dosing and long-term post-dosing clinical data. The modeling fitness estimates were robust in sensitivity analyses in which the restoration dynamics of replication space and assumptions of HCV mutation rates were varied.
Using 10.1 × 109 J/ψ events produced by the Beijing Electron Positron Collider (BEPCII) at a center-of-mass energy √s = 3.097 GeV and collected with the BESIII detector, we present a search for the rare semi-leptonic decay J/ψ → D−e+νe + c.c. No excess of signal above background is observed, and an upper limit on the branching fraction ℬ(J/ψ → D−e+νe + c. c.) < 7.1 × 10−8 is obtained at 90% confidence level. This is an improvement of more than two orders of magnitude over the previous best limit.
The process e+e−→ϕη is studied at 22 center-of-mass energy points (√s) between 2.00 and 3.08 GeV using 715 pb−1 of data collected with the BESIII detector. The measured Born cross section of e+e−→ϕη is found to be consistent with BABAR measurements, but with improved precision. A resonant structure around 2.175 GeV is observed with a significance of 6.9σ with mass (2163.5±6.2±3.0) MeV/c2 and width (31.1+21.1−11.6±1.1) MeV, where the first uncertainties are statistical and the second are systematic.